Exercise Training for Hispanics with Multiple Sclerosis
Delivery of a Culturally Tailored Exercise Training Intervention for Hispanics With Multiple Sclerosis
Recruiting
N/AInterventional Study
Multiple Sclerosis
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Ready to participate?
Review the details below, then apply to join this clinical trial.
At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Supportive Care
Participants needed
66 (estimated)
Sponsor
The University of Texas Health Science Center, Houston · Other
Who this trial is looking for
This trial is looking for Hispanic or Latino individuals diagnosed with multiple sclerosis. Participants will engage in a 16-week exercise program to help improve walking ability.
Are You a Good Fit for This Trial?
You may be able to join if
I have been diagnosed with MS
I have not had an MS relapse in the past 30 days
I identify as Hispanic or Latino
I have walking disability
I am willing to complete questionnaires and be randomly assigned
I speak English or Spanish as my primary language
You may not be able to join if
I have significant risks or contraindications for exercise
Summarized in plain language from this trial's official eligibility criteria.
The full criteria are further down this page — only the research team can
confirm whether you qualify.
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
The purpose of this study is to establish differences in the primary outcome of walking dysfunction using the 12-Item Multiple Sclerosis Walking Scale (MSWS-12) and to establish differences in the secondary outcome of HRQoL using the 29-Item Multiple Sclerosis Walking Scale (MSWS-29) between the exercise training intervention condition and the waitlist control condition following the 16-week inter…
The purpose of this study is to establish differences in the primary outcome of walking dysfunction using the 12-Item Multiple Sclerosis Walking Scale (MSWS-12) and to establish differences in the secondary outcome of HRQoL using the 29-Item Multiple Sclerosis Walking Scale (MSWS-29) between the exercise training intervention condition and the waitlist control condition following the 16-week intervention period.
Trial Locations
Loading…
Loading trial locations…
Facility
City
State
Country
Status
Eligibility Criteria
Inclusion Criteria:
* diagnosis of MS
* relapse-free in the past 30 days
* self-identify as Hispanic/Latino
* Patient Determined Disease Steps Scale (PDDS) score between 3.0 (gait disability) and 6.0 (bilateral support) indicates walking disability.
* MSWS-12 score between 25 and 75, indicating wal…
Inclusion Criteria:
* diagnosis of MS
* relapse-free in the past 30 days
* self-identify as Hispanic/Latino
* Patient Determined Disease Steps Scale (PDDS) score between 3.0 (gait disability) and 6.0 (bilateral support) indicates walking disability.
* MSWS-12 score between 25 and 75, indicating walking disability
* Willingness to complete the questionnaires and undergo randomization
* English or Spanish as a primary language
Exclusion Criteria:
* significant exercise-related risk factors or contraindications, assessed individually using the Physical Activity Readiness Questionnaire (PAR-Q; requires clearance from physician).
Picking one helps us show the most relevant trials first.
Your results are loading in the background — you can
change this any time from the results page.
Set your location to continue
Find My Trials uses your location to surface clinical trials near you.
Add your city or zip code to your profile and try again.